Healthcare / Health Information ServicesNasdaqCM
$3.37
+0.09 (+2.74%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 23%
FCF escenarios
weak_data · normalized FCF $-5.6M · quality 60.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
21/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$8M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-56.4%
↓Gross Margin
9.0%
↓Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2025 · 4 años de histórico normalizado
Revenue CAGR
+5.9%
FCF CAGR
—
FCF margin
-9729.4%
FCF / Net income
1.02x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $75730.0 · net income $-7.2M · FCF $-7.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | $75730.00 | $75730.00 | $45724.00 | $75404.00 | $60444.00 | $60292.00 |
| Net Income | $-7.2M | $-7.2M | $-7.0M | $-4.9M | $-7.1M | $-5.0M |
| EBITDA | $-7.0M | $-7.0M | $-6.3M | $-4.1M | $-5.4M | $-2.8M |
| EPS | — | — | -5151.64 | -53971.14 | -138594.74 | -952257.60 |
| Gross Margin | 9.0% | 9.0% | -85.2% | -0.4% | -8.0% | -14.7% |
| Operating Margin | -9312.5% | -9312.5% | -12057.2% | -6468.0% | -9202.5% | -4897.9% |
| Net Margin | -9551.9% | -9551.9% | -15293.8% | -6513.4% | -11694.4% | -8210.5% |
| Balance Sheet | ||||||
| Debt/Equity | — | — | — | -1.55 | — | — |
| Current Ratio | 19.65 | 19.65 | — | — | — | — |
| Cash Flow | ||||||
| Free Cash Flow | $-7.4M | $-7.4M | $-5.6M | $-3.8M | $-5.2M | — |
| Returns | ||||||
| ROE | -56.4% | -56.4% | -720.9% | 674.6% | -317.6% | 38.6% |
| Valuation | ||||||
| P/B | 0.22 | 0.22 | 3.80 | — | 2.04 | — |
| Growth & Yield | ||||||
| Revenue Growth | 65.6% | 65.6% | -39.4% | 24.8% | — | — |
| EPS Growth | — | — | 90.5% | 61.1% | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-48.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-5151.64 → n/d
Residual
-48.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.